C12N 2310/532
Closed or circular
C12N2310/532 (Closed or circular) appears on 67 US grants and 194 published applications in this corpus.
Search patents in C12N- Granted patents
- 67
- Published applications
- 194
- Assignees
- 126
- Inventors
- 486
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 3 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 1 | 3 |
| 2016 | 1 | 3 |
| 2017 | 2 | 2 |
| 2018 | 1 | 5 |
| 2019 | 5 | 6 |
| 2020 | 3 | 18 |
| 2021 | 4 | 15 |
| 2022 | 7 | 23 |
| 2023 | 15 | 32 |
| 2024 | 11 | 19 |
| 2025 | 11 | 30 |
| 2026 | 5 | 31 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- RNA molecules, methods of producing circular RNA, and treatment methods15 Sep 2026US 12,737,877 B2Cornell University
- Nanocaged enzymes with enhanced catalytic activity and increased stability16 Jun 2026US 12,655,415 B2Arizona Board of Regents on behalf of Arizona State University
- Compositions and methods for circular RNA expression14 Apr 2026US 12,600,987 B2Duke University
- Methods and compositions relating to covalently closed nucleic acids10 Mar 2026US 12,571,024 B2Twist Bioscience Corporation
- Nucleic acid mazzocchio and methods of making and use thereof3 Mar 2026US 12,564,637 B2The University of Hong Kong
- Gel Analysis of RNA1 Oct 2026US 2026/0297556 A1
- Novel internal ribosome entry site (ires) and intron sequences1 Oct 2026US 2026/0297579 A1Ginkgo Bioworks, Inc.
- Hiv vaccine24 Sep 2026US 2026/0284176 A1
- Circular single-stranded dna molecules for recombinase-based gene editing17 Sep 2026US 2026/0275344 A1Fc IP Holdings, LLC
- Synthetic circuits and uses thereof17 Sep 2026US 2026/0275375 A1Strand Therapeutics Inc.
Most cited
By later US patents
- Gene expression control32US 6,133,024 AAventis Pharma S. A. · 2000
- Vectors and methods for genetic immunization8US 9,737,620 B2Nature Technology Corporation · 2017
- Combination comprising immunostimulatory oligonucleotides7US 10,487,333 B2Mologen AG · 2019
- Circular RNA compositions and methods7US 11,603,396 B2Massachusetts Institute of Technology · 2023
- RNA templated ligation6US 11,597,965 B210x Genomics, Inc. · 2023